(Press-News.org) Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.
There is ongoing debate surrounding allergic diseases and their impact on the likelihood of developing cancer, with some studies suggesting that eczema is associated with a reduced risk of skin cancer. However, it is difficult to draw firm conclusions based on studies of human populations because eczema symptoms vary in severity and drugs used to treat the condition might also influence cancer. Published today in eLife, the study by researchers at King's College London is the first to show that allergy caused by the skin defects could actually protect against skin cancer.
Skin cancer is a common and growing problem, accounting for one in every three cancers diagnosed worldwide, according to the World Health Organization. Recent findings suggest that malignant melanoma, the most dangerous form of skin cancer, is now five times more common in the UK than it was in the 1970s.
Eczema can result from the loss of structural proteins in the outermost layers of the skin, leading to a defective skin barrier. Genetically engineered mice lacking three skin barrier proteins ('knock-out' mice) were used in the King's study to replicate some of the skin defects found in eczema sufferers.
The researchers, funded by the Medical Research Council (MRC), the Wellcome Trust and Cancer Research UK, compared the effects of two cancer-causing chemicals in normal mice and mice with the barrier defect (the knock-out mice). The number of benign tumours per mouse was six times lower in knock-out mice than in normal mice. The findings suggest that defects in the epidermal barrier protected the genetically engineered mice against benign tumour formation.
Researchers found that both types of mice were equally susceptible to acquiring cancer-causing mutations. However, an exaggerated inflammatory reaction in knock-out mice led to enhanced shedding of potentially cancerous cells from the skin. This cancer-protective mechanism bears similarities to that which protects skin from environmental assaults such as bacteria.
Professor Fiona Watt, Director of the Centre for Stem Cells and Regenerative Medicine, said: 'We are excited by our findings as they establish a clear link between cancer susceptibility and an allergic skin condition in our experimental model. They also support the view that modifying the body's immune system is an important strategy in treating cancer.
'I hope our study provides some small consolation to eczema sufferers – that this uncomfortable skin condition may actually be beneficial in some circumstances.'
Dr Mike Turner, Head of Infection and Immunobiology at the Wellcome Trust, said: 'Skin cancer is on the rise in many countries and any insight into the body's ability to prevent tumour formation is valuable in the fight against this form of cancer. These findings that eczema can protect individuals from skin cancer support theories linking allergies to cancer prevention and open up new avenues for exploration whilst providing some (small) comfort for those suffering from eczema.'
INFORMATION:
For further information please contact Jack Stonebridge, Press Officer at King's College London, on 0207 848 3202 or email pr@kcl.ac.uk
Notes to editors:
King's College London
King's College London is one of the top 20 universities in the world (2013/14 QS World University Rankings), and the fourth oldest in England. A research-led university based in the heart of London, King's has nearly 23,500 students (of whom more than 9,000 are graduate students) from nearly 140 countries, and some 6,000 employees. King's is in the second phase of a £1 billion redevelopment programme which is transforming its estate.
King's has an outstanding reputation for providing world-class teaching and cutting-edge research. In the 2008 Research Assessment Exercise for British universities, 23 departments were ranked in the top quartile of British universities; over half of our academic staff work in departments that are in the top 10 per cent in the UK in their field and can thus be classed as world leading. The College is in the top seven UK universities for research earnings and has an overall annual income of nearly £450 million.
King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.
King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit: http://www.kingshealthpartners.org.
About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests. http://www.wellcome.ac.uk
Having eczema may reduce your risk of skin cancer
2014-05-06
ELSE PRESS RELEASES FROM THIS DATE:
Annals of Internal Medicine tip sheet for May 6, 2014
2014-05-06
1. Deaths decline after Massachusetts' health care reform
Deaths declined significantly in Massachusetts four years after comprehensive health care reform, according to an article being published in Annals of Internal Medicine. In 2006, Massachusetts enacted a health care law that expanded Medicaid, offered subsidized private insurance, and created an individual mandate. As the model for the Affordable Care Act, effects of the Massachusetts' health care overhaul have important policy implications. Researchers wanted to find out if expanded insurance coverage affected ...
Significant decline in deaths after Massachusetts' health reform
2014-05-06
Boston, MA — In the first four years after Massachusetts instituted comprehensive health reform in 2006, mortality in the state decreased by 2.9% compared with similar populations in states that didn't expand health coverage, according to a new study led by Harvard School of Public Health (HSPH) researchers. They estimated that Massachusetts' health reform law, which provided near-universal coverage, has prevented approximately 320 deaths per year—one life saved for each 830 people gaining insurance.
The study—which provides new scientifically rigorous analysis of whether ...
What fuels Salmonella's invasion strategy?
2014-05-06
Certain strains of Salmonella bacteria such as Salmonella Typhimurium (S. Typhimurium) are among of the most common causes of food-borne gastroenteritis. Other strains of Salmonella such as S. Typhi are responsible for typhoid fever, which causes 200,000 deaths around the world each year. Ensuring food is clear of contamination, and water is clean are key to reducing the effects Salmonella can have, but we also need more effective ways to combat Salmonella once it's inside our bodies.
To address this the Institute of Food Research, strategically supported by the Biotechnology ...
Rising treatment costs drive up health care spending
2014-05-05
It's a well-known fact that spending on health care has consistently grown faster than the rest of the U.S. economy. What's behind this trend is less certain. Economists point to two causes: the prevalence of diseases and conditions afflicting the U.S. population, or the rising costs of treating diseases. New research from American University Associate Professor Martha Starr and Virginia Tech Research Professor Ana Aizcorbe shows it is the latter, with higher prices for treatment accounting for 70 percent of growth in health care spending.
"Rising costs of treatment ...
Active seniors can lower heart attack risk by doing more, not less
2014-05-05
Maintaining or boosting your physical activity after age 65 can improve your heart's electrical well-being and lower your risk of heart attack, according to a study in the American Heart Association journal Circulation.
In heart monitor recordings taken over five years, researchers found that people who walked more and faster and had more physically active leisure time had fewer irregular heart rhythms and greater heart rate variability than those who were less active.
Heart rate variability is differences in the time between one heartbeat and the next during everyday ...
Henry Ford Hospital study links social, community factors with hospital readmissions
2014-05-05
DETROIT – Factors like the level of poverty in a neighborhood, living alone, and age affect a patient's chances of being readmitted to a hospital after discharge, even after possible variations in quality of care in the hospital have been taken into account.
Those are the conclusions of a new study by Henry Ford Health System researchers who found links between readmission rates and social factors such as patients' marital status and neighborhood poverty, suggesting that readmissions are not just an issue of hospital quality.
The study appears in the May issue of Health ...
Lower Hispanic participation in Medicare drug benefit may point to barriers
2014-05-05
Hispanic seniors are 35 percent less likely to have prescription drug coverage despite the existence of the Medicare Prescription Drug Plan – also known as Part D – and the availability of assistance to help pay insurance premiums. That is the finding of a study released today in the journal Health Affairs.
"These results indicate that disparities in prescription drug coverage exist between Hispanic and white Medicare beneficiaries, despite the existence of a potentially universal entitlement program," said Brian McGarry, a graduate student in the Department of Public ...
Study looks at predicting fracture risk after women stop bisphosphonate therapy
2014-05-05
Age and testing of hip bone mineral density (BDM) when postmenopausal women discontinue bisphosphonate therapy can help predict the likelihood of fractures over the next five years.
Bisphosphonates can reduce the risk of hip and spine fractures. But recent concerns about safety issues, including osteonecrosis of the jaw, atypical femoral fractures and esophageal cancer, have increased interest in interrupting or stopping bisphosphonate therapy after several years of treatment. This study tested methods for predicting fracture risk by measuring BMD using hip and spine ...
Choosing a screening method for cervical cancer: Pap alone or with HPV test
2014-05-05
Karen Smith-McCune, M.D., Ph.D., of the University of California, San Francisco, writes: "The updated guidelines leave physicians and other clinicians with a question: is cotesting with Pap-plus-HPV testing truly preferred over Pap testing alone (the American Cancer Society/the American Society of Colposcopy and Cervical Pathology/the American Society of Clinical Pathology recommendation), or are the options equivalent (the U.S. Preventive Services Task Force recommendation)?"
"Once a straightforward process, screening for cervical cancer is now increasingly complex. ...
Eliminating copayments improves adherence, reduces adverse events in nonwhite patients
2014-05-05
Research demonstrates that lowering copayments for cardiovascular medications results in better adherence and outcomes among all patients, but until now, little was known about whether lowering copayments could improve known disparities in cardiovascular care. New research finds that lowering copayments for medications following a heart attack could have a significant impact on reducing the racial and ethnic disparities that exist in cardiovascular disease.
These findings are published in the May issue of Health Affairs.
"African Americans and Hispanics with cardiovascular ...